9786206179306 - biomarkers and its clinical implication: an update de patel, dr avani; attur, dr. shylaja; chaudhary, dr. reena (8 resultados)
- Tapa blanda
Librería: Books Puddle, New York, NY, Estados Unidos de AmericaBooks Puddle
Contactar con el vendedorVendedor de 4 estrellasCondición: Nuevo
EUR 87,85
Envío por EUR 3,49Se envía dentro de Estados Unidos de AmericaCantidad disponible: 4 disponibles
Condición: New.
- Tapa blanda
- Impresión bajo demanda
Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, AlemaniaBuchWeltWeit Ludwig Meier e.K.
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 68,90
Envío por EUR 23,00Se envía de Alemania a Estados Unidos de AmericaCantidad disponible: 2 disponibles
Taschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Tumor markers hold the promise of a revolution in disease diagnosis and therapeutic monitoring, provided that major challenges in genomics, proteomics and related disciplines can be addressed. The regulatory standards to be met by n…ew measurement technologies for the clinical laboratory are very high. The measurements must not only be accurate, they must have a concrete medical implication. Squamous cell carcinomas (SCCs) show various clinical and histological features according to their epithelial differentiation stage. Generally, poorly differentiated SCCs are known to grow more rapidly and spread diffusely, resulting in poor prognosis while well-differentiated SCCs are resistant to chemotherapy and radiotherapy. A more sophisticated understanding of the pathogenesis and the identification of better biological markers could provide useful information for predicting outcome and individualizing treatment. In this context, much attention has been focused on the role of peptide growth factors and their receptors. 144 pp. Englisch.
- Tapa blanda
- Impresión bajo demanda
Librería: Majestic Books, Hounslow, Reino UnidoMajestic Books
Contactar con el vendedorVendedor de 4 estrellasCondición: Nuevo
EUR 89,55
Envío por EUR 7,59Se envía de Reino Unido a Estados Unidos de AmericaCantidad disponible: 4 disponibles
Condición: New. Print on Demand.
- Tapa blanda
- Impresión bajo demanda
Librería: Biblios, frankfurt am main, HESSE, AlemaniaBiblios
Contactar con el vendedorVendedor de 4 estrellasCondición: Nuevo
EUR 90,05
Envío por EUR 9,95Se envía de Alemania a Estados Unidos de AmericaCantidad disponible: 4 disponibles
Condición: New. PRINT ON DEMAND.
- Tapa blanda
- Impresión bajo demanda
Librería: moluna, Greven, Alemaniamoluna
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 55,87
Envío por EUR 48,99Se envía de Alemania a Estados Unidos de AmericaCantidad disponible: Más de 20 disponibles
Condición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Tumor markers hold the promise of a revolution in disease diagnosis and therapeutic monitoring, provided that major challenges in genomics, proteomics and related disciplines can be addressed. The regulatory standards… to be met by new measurement technologi.
- Tapa blanda
- Impresión bajo demanda
Librería: preigu, Osnabrück, Alemaniapreigu
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 58,00
Envío por EUR 70,00Se envía de Alemania a Estados Unidos de AmericaCantidad disponible: 5 disponibles
Taschenbuch. Condición: Neu. Biomarkers and Its Clinical Implication | An Update | Avani Patel (u. a.) | Taschenbuch | Englisch | 2023 | LAP LAMBERT Academic Publishing | EAN 9786206179306 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu… Print on Demand.
- Tapa blanda
- Impresión bajo demanda
Librería: buchversandmimpf2000, Emtmannsberg, BAYE, Alemaniabuchversandmimpf2000
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 68,90
Envío por EUR 60,00Se envía de Alemania a Estados Unidos de AmericaCantidad disponible: 1 disponibles
Taschenbuch. Condición: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Tumor markers hold the promise of a revolution in disease diagnosis and therapeutic monitoring, provided that major challenges in genomics, proteomics and related disciplines can be addressed. The regulatory standards to be met by new m…easurement technologies for the clinical laboratory are very high. The measurements must not only be accurate, they must have a concrete medical implication. Squamous cell carcinomas (SCCs) show various clinical and histological features according to their epithelial differentiation stage. Generally, poorly differentiated SCCs are known to grow more rapidly and spread diffusely, resulting in poor prognosis while well-differentiated SCCs are resistant to chemotherapy and radiotherapy. A more sophisticated understanding of the pathogenesis and the identification of better biological markers could provide useful information for predicting outcome and individualizing treatment. In this context, much attention has been focused on the role of peptide growth factors and their receptors.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 144 pp. Englisch.
- Tapa blanda
- Impresión bajo demanda
Librería: AHA-BUCH GmbH, Einbeck, AlemaniaAHA-BUCH GmbH
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 69,73
Envío por EUR 61,17Se envía de Alemania a Estados Unidos de AmericaCantidad disponible: 1 disponibles
Taschenbuch. Condición: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Tumor markers hold the promise of a revolution in disease diagnosis and therapeutic monitoring, provided that major challenges in genomics, proteomics and related disciplines can be addressed. The regulatory standards to be met by new me…asurement technologies for the clinical laboratory are very high. The measurements must not only be accurate, they must have a concrete medical implication. Squamous cell carcinomas (SCCs) show various clinical and histological features according to their epithelial differentiation stage. Generally, poorly differentiated SCCs are known to grow more rapidly and spread diffusely, resulting in poor prognosis while well-differentiated SCCs are resistant to chemotherapy and radiotherapy. A more sophisticated understanding of the pathogenesis and the identification of better biological markers could provide useful information for predicting outcome and individualizing treatment. In this context, much attention has been focused on the role of peptide growth factors and their receptors.
